ATE286058T1 - Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung - Google Patents

Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung

Info

Publication number
ATE286058T1
ATE286058T1 AT00901914T AT00901914T ATE286058T1 AT E286058 T1 ATE286058 T1 AT E286058T1 AT 00901914 T AT00901914 T AT 00901914T AT 00901914 T AT00901914 T AT 00901914T AT E286058 T1 ATE286058 T1 AT E286058T1
Authority
AT
Austria
Prior art keywords
compounds
thiazolpyrimidine
production
application
optionally substituted
Prior art date
Application number
AT00901914T
Other languages
English (en)
Inventor
Shigenori Ohkawa
Naoyuki Kanzaki
Seiji Miwatashi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE286058T1 publication Critical patent/ATE286058T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00901914T 1999-01-28 2000-01-27 Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung ATE286058T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1982899 1999-01-28
PCT/JP2000/000395 WO2000044756A1 (fr) 1999-01-28 2000-01-27 Composes de thiazolopyrimidine, et methodes de preparation et d'utilisation correspondantes

Publications (1)

Publication Number Publication Date
ATE286058T1 true ATE286058T1 (de) 2005-01-15

Family

ID=12010167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901914T ATE286058T1 (de) 1999-01-28 2000-01-27 Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung

Country Status (7)

Country Link
US (1) US6583146B1 (de)
EP (1) EP1148059B1 (de)
AT (1) ATE286058T1 (de)
AU (1) AU2319000A (de)
CA (1) CA2359011A1 (de)
DE (1) DE60017084T2 (de)
WO (1) WO2000044756A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001290243A1 (en) * 2000-09-20 2002-04-02 Nikken Chemicals Co., Ltd. Novel thiazole bicyclic compounds
WO2005026166A1 (fr) * 2003-09-16 2005-03-24 'chemical Diversity Research Institute', Ltd. Composition physiologiquement active, composition pharmaceutique, 1,2-dihydro[2,7]naphtyridine, procedes de fabrication et application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919201A (en) * 1970-09-30 1975-11-11 Lilly Industries Ltd 2-({62 -Aminoacryloyl)iminobenzothiazolines
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
WO1997033879A1 (en) 1996-03-15 1997-09-18 Merck & Co., Inc. Compounds and methods for selectively inhibiting activation of the human a3 adenosine receptor

Also Published As

Publication number Publication date
AU2319000A (en) 2000-08-18
DE60017084T2 (de) 2005-12-22
DE60017084D1 (de) 2005-02-03
US6583146B1 (en) 2003-06-24
EP1148059B1 (de) 2004-12-29
EP1148059A4 (de) 2002-04-10
EP1148059A1 (de) 2001-10-24
CA2359011A1 (en) 2000-08-03
WO2000044756A1 (fr) 2000-08-03

Similar Documents

Publication Publication Date Title
PT885210E (pt) Compostos triciclicos que possuem afinidade de ligacao para receptores de melatonina sua producao e utilizacao
ATE242241T1 (de) Imidazopyridinderivate und verfahren zu ihrer herstellung
WO1999000373A8 (fr) Derives de benzimidazole
DE3576955D1 (de) Beta-carbolin-3-oxadiazolylderivate, verfahren zu ihrer herstellung und ihre verwendung.
CO4340625A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
DE60006857D1 (de) Verfahren zur herstellung von pyridinmethanol-verbindungen
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE376830T1 (de) Benzo(b(thiophenderivate und verfahren zu deren herstellung
ATE286058T1 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
ATE293628T1 (de) Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
HRP980646B1 (en) Novel oleandomycin derivatives
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
DE59001784D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE60009893D1 (de) Benzoxazol-derivate, verfahren zu ihrer herstellung und herbizide
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
ATE170188T1 (de) 2'-desoxy-5-fluoruridin, pharmazeutisch anwendbare salze davon, verfahren zu ihrer herstellung und antitumormedikament
DE69618817D1 (de) Fungizide substanzen be-49385 und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties